Page last updated: 2024-10-23

bumetanide and Allergic Encephalomyelitis

bumetanide has been researched along with Allergic Encephalomyelitis in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Treatment with bumetanide, an NKCC inhibitor, had no effect on mechanical hypersensitivity seen in mice with EAE even though it reversed the changes in the levels of NKCC1 and KCC2."1.46The chloride co-transporters, NKCC1 and KCC2, in experimental autoimmune encephalomyelitis (EAE). ( Kerr, B; Tenorio, G; Yousuf, MS; Zubkow, K, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yousuf, MS1
Zubkow, K1
Tenorio, G1
Kerr, B1

Other Studies

1 other study available for bumetanide and Allergic Encephalomyelitis

ArticleYear
The chloride co-transporters, NKCC1 and KCC2, in experimental autoimmune encephalomyelitis (EAE).
    Neuroscience, 2017, 03-06, Volume: 344

    Topics: Animals; Bumetanide; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Gangl

2017
chemdatabank.com